Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 98.00
+3.50 (3.70%)
Jul 24, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 542.16 million as of July 24, 2026. Its market cap has increased by 3.86% in one year.
Market Cap
542.16M
Enterprise Value
481.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
98.00
ChartMarket Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 542.16M, an increase of 371.29%. That is a compound annual growth rate of 38.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 542.16M | 41.88% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 585.29M |
| Captor Therapeutics Spolka Akcyjna | 479.05M |
| Ryvu Therapeutics | 346.80M |
| BIOTON | 330.15M |
| Synthaverse | 208.37M |
| Poltreg | 138.45M |
| Molecure | 122.59M |
| Mabion | 119.12M |